Research and Markets: Interferon Market Has Been Growing at an Average Annual Growth Rate of 17% over Past Five Years.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c21660) has announced the addition of Interferon Current Market Dynamics & Future Outlook to their offering At the end of 2004 the world market for Interferon was valued at $5.9 billion, a growth of 13% over 2003. The market has been growing at an average annual growth rate of 17% over the previous 5 years. The interferon market is application driven and clearly demarcated along the lines of the type of the interferon molecule. At 60% share, interferon Beta interferon beta Fibroblast interferon IFN-β A 20 kD anti-viral protein with 30% 'homology' with IFN alpha, encoded on chromosome 9, produced by fibroblasts in response to viruses or polyribonucleotides accounts for the main bulk of the market followed by interferon Alfa at 37% market share. Interferon alfa therapy is used as a frontline treatment for a number of indications including the treatment of malignant melanoma, hairy cell leukemia Hairy Cell Leukemia Definition Hairy cell leukemia is a disease in which a type of white blood cell called the lymphocyte, present in the blood and bone marrow, becomes malignant and proliferates. , chronic hepatitis B, chronic hepatitis C, condylomata acuminata, follicular fol·lic·u·lar adj. 1. Relating to, having, or resembling a follicle or follicles. 2. Affecting or growing out of a follicle or follicles. (non-Hodgkin's) lymphoma, and AIDS-related Kaposi's sarcoma Worldwide, 350 million people are thought to be chronically infected with HBV HBV hepatitis B virus. HBV abbr. hepatitis B virus , a highly infectious pathogen that is responsible for an estimated 1 million deaths annually and more than 170 million people are infected with HCV HCV abbr. hepatitis C virus HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus. with 3 to 4 million new cases occurring each year. The main indication for interferon beta is Multiple Sclerosis (MS), a disease of the central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ), affecting over 400,000 people in the US and 1.2 million in the developed world. Interferon - Current Market Dynamics & Future Outlook is a timely strategic consulting report assessing both the technology status and the competitive landscape of Interferon Alfa, Beta & Gamma and their application areas. The report profiles leading products and companies and offers revenue forecasts to the year 2010. Companies/brands mentioned: - Roche - Schering Plough - Sumitomo - Takeda - GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) - Hemispheric - GeneMedix - Novartis / Sandoz - Ratiopharm / BioGeneriX - Biogen Idec - Avonex - Serono - Rebif - Schering Ag / Berlex - Betaseron / Betaferon For more information visit http://www.researchandmarkets.com/reports/c21660 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion